ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2018

Elevated Serum Levels of Tie-1 in Patients with Rheumatoid Arthritis

Dylan Lee1, Chandra Mohan 2, Danielle Feger 3, Nancy Olsen 4 and Rayford June 4, 1Pennsylvania State M.S. Hershey Medical Center, Hershey, PA, 2Department of Biomedical Engineering, University of Houston,, Houston, 3Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health,, Baltimore, 4Pennsylvania State M.S. Hershey Medical Center, Hershey

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Angiogenesis, rheumatoid arthritis (RA) and rheumatologic disease, tie

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Etiology & Pathogenesis Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease that primarily affects patients’ peripheral joints and can lead to severe personal disability from progressive articular joint destruction.  The cause of RA is unknown.  Recent studies have shown that collagen formation as well as angiogenesis are important in the pathophysiology of this disease. Specifically, serum vascular endothelial factor (VEGF) levels have been shown to be elevated in patients with RA and were correlated with the degree of radiographic joint damage.  In addition to VEGF, a related angiogenic factor Tie-1 has been found to be elevated in RA synovial fluid.  The objective of this study was to determine serum levels of Tie-1 in patients with RA and investigate associations with RA disease activity and RA clinical features.

Methods: 94 patients with RA and 21 healthy controls from the Penn State Hershey Investigation of Remission in Rheumatoid Arthritis (IRRA) cohort at Pennsylvania State M.S. Hershey Medical Center had measurement of serum Tie-1 levels using ELISA.  High levels of Tie-1 were considered to be greater than 35,000.  Mean Tie-1 levels were compared by T-test.  Further analysis was performed using other available data including DAS 28 ESR/CRP, age, disease duration and mHAQ using Pearson’s correlation and linear regression. Further chart review analysis was done to correlate radiographic findings.  Data are expressed as mean (standard deviation). 

Results:  The 94 subjects with RA had significantly higher serum Tie-1 levels compared to the healthy controls (19,794.91 (13,373.99) vs. 15,388.67 (9,935.25), p=0.027, Table 1a).  There was a mild association between Tie-1 and DAS28ESR (β estimate 0.072; p=0.069).  Eight subjects had high levels of Tie-1;  6 of these 8 patients had erosions on their x-rays (Table 1b). Patients with erosions had higher Tie-1 levels, but this was not statistically significant (P=0.125).

Conclusion: RA patients have higher levels of Tie-1 compared to healthy controls (Figure 1).  High Tie-1 levels had a mild correlation with RA disease activity in this cross-sectional analysis. The etiology for the reason for higher levels of this angiogenesis factor in RA is unknown but may be related to synovial proliferation and other features of uncontrolled disease.  Further research is needed to investigate the mechanism and source of the increase in serum and synovial fluid levels of TIE-1 and study as a biomarker of disease will be also of interest. These findings, combined with the previously described correlation between VEGF and RA activity, support the need to further understand the role of angiogenesis in the pathogenesis of RA.

Figure 1: Serum Levels of TIE-1


Disclosure: D. Lee, None; C. Mohan, None; D. Feger, None; N. Olsen, None; R. June, None.

To cite this abstract in AMA style:

Lee D, Mohan C, Feger D, Olsen N, June R. Elevated Serum Levels of Tie-1 in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/elevated-serum-levels-of-tie-1-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/elevated-serum-levels-of-tie-1-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology